Oruka Therapeutics, Inc. Operating Cash Flow
Oruka Therapeutics, Inc. (ORKA) reported Operating Cash Flow of -$56.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- Oruka Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$33.15M.
- Oruka Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$23.58M.
- Oruka Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$22.59M.
- Oruka Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$21.60M.
- Oruka Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$88.21M.
- Oruka Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$5.01M.
- Oruka Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$10.91M.
- Oruka Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$18.76M.
| Period end | Net Cash Provided by (Used in) Operating Activities 2 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 5 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 8 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 11 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 24 month | Net Cash Provided by (Used in) Operating Activities 114 month | Net Cash Provided by (Used in) Operating Activities 117 month | Net Cash Provided by (Used in) Operating Activities 120 month | Net Cash Provided by (Used in) Operating Activities 123 month | Net Cash Provided by (Used in) Operating Activities 126 month | Net Cash Provided by (Used in) Operating Activities 129 month | Net Cash Provided by (Used in) Operating Activities 132 month | Net Cash Provided by (Used in) Operating Activities 135 month | Net Cash Provided by (Used in) Operating Activities 138 month | Net Cash Provided by (Used in) Operating Activities 141 month | Net Cash Provided by (Used in) Operating Activities 144 month | Net Cash Provided by (Used in) Operating Activities 147 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$33.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$56.72M 10-Q · filed 2026-08-10 | -$79.32M derived: sum of 3 quarters · filed 2026-08-10 | -$100.92M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||||||
| 2026-03-31 | -$23.58M 10-Q · filed 2026-05-13 | -$46.17M derived: sum of 2 quarters · filed 2026-05-13 | -$67.77M derived: sum of 3 quarters · filed 2026-05-13 | -$90.92M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||||||
| 2025-12-31 | -$22.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$44.20M derived: sum of 2 quarters · filed 2026-03-12 | -$67.34M derived: sum of 3 quarters · filed 2026-08-10 | -$88.21M 10-K · filed 2026-03-12 | |||||||||||||||||
| 2025-09-30 | -$21.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$44.75M derived: sum of 2 quarters · filed 2026-08-10 | -$65.62M 10-Q · filed 2025-11-12 | ||||||||||||||||||
| 2025-06-30 | -$23.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$44.01M 10-Q · filed 2026-08-10 | |||||||||||||||||||
| 2025-03-31 | -$20.87M 10-Q · filed 2026-05-13 | ||||||||||||||||||||
| 2024-12-31 | -$57.84M 10-K · filed 2026-03-12 | ||||||||||||||||||||
| 2024-09-30 | -$39.02M 10-Q · filed 2025-11-12 | ||||||||||||||||||||
| 2024-06-30 | -$2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$11.20M 10-Q · filed 2025-08-11 | -$4.16M 10-Q · filed 2024-08-01 | -$5.22M derived: sum of 3 quarters · filed 2024-08-01 | -$6.89M derived: sum of 4 quarters · filed 2024-08-01 | ||||||||||||||||
| 2024-03-31 | -$168.00K 10-Q · filed 2025-05-14 | -$1.53M 10-Q · filed 2024-04-25 | -$2.58M derived: sum of 2 quarters · filed 2024-04-25 | -$4.25M derived: sum of 3 quarters · filed 2024-04-25 | -$4.95M derived: sum of 4 quarters · filed 2024-08-01 | ||||||||||||||||
| 2023-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | -$2.73M derived: sum of 2 quarters · filed 2024-02-01 | -$3.42M derived: sum of 3 quarters · filed 2024-08-01 | -$5.01M 10-K · filed 2024-02-01 | |||||||||||||||||
| 2023-09-30 | -$1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-18 | -$2.36M derived: sum of 2 quarters · filed 2024-08-01 | -$3.96M 10-Q · filed 2023-10-18 | -$5.45M derived: sum of 4 quarters · filed 2024-08-01 | |||||||||||||||||
| 2023-06-30 | -$694.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$2.29M 10-Q · filed 2024-08-01 | -$3.78M derived: sum of 3 quarters · filed 2024-08-01 | -$6.28M derived: sum of 4 quarters · filed 2024-08-01 | |||||||||||||||||
| 2023-03-31 | -$1.59M 10-Q · filed 2024-04-25 | -$3.09M derived: sum of 2 quarters · filed 2024-04-25 | -$5.59M derived: sum of 3 quarters · filed 2024-04-25 | -$8.21M derived: sum of 4 quarters · filed 2024-04-25 | |||||||||||||||||
| 2022-12-31 | -$1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | -$3.99M derived: sum of 2 quarters · filed 2024-02-01 | -$6.61M derived: sum of 3 quarters · filed 2024-02-01 | -$10.91M 10-K · filed 2024-02-01 | |||||||||||||||||
| 2022-09-30 | -$2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-18 | -$5.12M derived: sum of 2 quarters · filed 2023-10-18 | -$9.42M 10-Q · filed 2023-10-18 | -$14.37M derived: sum of 4 quarters · filed 2023-10-18 | |||||||||||||||||
| 2022-06-30 | -$2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-21 | -$6.92M 10-Q · filed 2023-07-21 | -$11.87M derived: sum of 3 quarters · filed 2023-07-21 | -$16.74M derived: sum of 4 quarters · filed 2023-07-21 | |||||||||||||||||
| 2022-03-31 | -$4.30M 10-Q · filed 2023-04-24 | -$9.24M derived: sum of 2 quarters · filed 2023-04-24 | -$14.12M derived: sum of 3 quarters · filed 2023-04-24 | -$17.84M derived: sum of 4 quarters · filed 2023-04-24 | |||||||||||||||||
| 2021-12-31 | -$4.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$9.82M derived: sum of 2 quarters · filed 2023-02-24 | -$13.54M derived: sum of 3 quarters · filed 2023-02-24 | -$18.76M 10-K · filed 2023-02-24 | |||||||||||||||||
| 2021-09-30 | -$4.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$8.59M derived: sum of 2 quarters · filed 2022-10-28 | -$13.81M 10-Q · filed 2022-10-28 | -$16.81M derived: sum of 4 quarters · filed 2022-10-28 | |||||||||||||||||
| 2021-06-30 | -$3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$8.95M 10-Q · filed 2022-08-02 | -$11.94M derived: sum of 3 quarters · filed 2022-08-02 | -$13.94M derived: sum of 4 quarters · filed 2022-08-02 | |||||||||||||||||
| 2021-03-31 | -$5.22M 10-Q · filed 2022-05-02 | -$8.22M derived: sum of 2 quarters · filed 2022-05-02 | -$10.22M derived: sum of 3 quarters · filed 2022-05-02 | -$11.26M derived: sum of 4 quarters · filed 2022-05-02 | |||||||||||||||||
| 2020-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -$5.00M derived: sum of 2 quarters · filed 2022-03-14 | -$6.04M derived: sum of 3 quarters · filed 2022-03-14 | -$7.72M 10-K · filed 2022-03-14 | |||||||||||||||||
| 2020-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$3.04M derived: sum of 2 quarters · filed 2021-11-02 | -$4.73M 10-Q · filed 2021-11-02 | -$5.89M derived: sum of 4 quarters · filed 2021-11-02 | |||||||||||||||||
| 2020-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$2.73M 10-Q · filed 2021-08-04 | -$3.89M derived: sum of 3 quarters · filed 2021-08-04 | -$4.77M derived: sum of 4 quarters · filed 2021-08-04 | |||||||||||||||||
| 2020-03-31 | -$1.69M 10-Q · filed 2021-05-11 | -$2.84M derived: sum of 2 quarters · filed 2021-05-11 | -$3.73M derived: sum of 3 quarters · filed 2021-05-11 | -$4.92M derived: sum of 4 quarters · filed 2021-05-11 | |||||||||||||||||
| 2019-12-31 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$2.04M derived: sum of 2 quarters · filed 2021-03-18 | -$3.23M derived: sum of 3 quarters · filed 2021-03-18 | -$4.80M 10-K · filed 2021-03-18 | |||||||||||||||||
| 2019-09-30 | -$887.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$2.08M derived: sum of 2 quarters · filed 2020-11-02 | -$3.64M 10-Q · filed 2020-11-02 | -$4.99M derived: sum of 4 quarters · filed 2020-11-02 | |||||||||||||||||
| 2019-06-30 | -$1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$2.76M 10-Q · filed 2020-08-05 | -$4.10M derived: sum of 3 quarters · filed 2020-08-05 | -$5.67M derived: sum of 4 quarters · filed 2020-08-05 | |||||||||||||||||
| 2019-03-31 | -$1.57M 10-Q · filed 2020-05-06 | -$2.91M derived: sum of 2 quarters · filed 2020-05-06 | -$4.49M derived: sum of 3 quarters · filed 2020-05-06 | -$6.74M derived: sum of 4 quarters · filed 2020-05-06 | |||||||||||||||||
| 2018-12-31 | -$1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$2.92M derived: sum of 2 quarters · filed 2020-02-18 | -$5.17M derived: sum of 3 quarters · filed 2020-02-18 | -$8.24M 10-K · filed 2020-02-18 | |||||||||||||||||
| 2018-09-30 | -$1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$3.83M derived: sum of 2 quarters · filed 2019-11-06 | -$6.90M 10-Q · filed 2019-11-06 | -$11.10M derived: sum of 4 quarters · filed 2019-11-06 | |||||||||||||||||
| 2018-06-30 | -$2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$5.33M 10-Q · filed 2019-08-01 | -$9.52M derived: sum of 3 quarters · filed 2019-08-01 | -$13.49M derived: sum of 4 quarters · filed 2019-08-01 | |||||||||||||||||
| 2018-03-31 | -$3.07M 10-Q · filed 2019-05-08 | -$7.27M derived: sum of 2 quarters · filed 2019-05-08 | -$11.24M derived: sum of 3 quarters · filed 2019-05-08 | ||||||||||||||||||
| 2017-12-31 | -$4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$8.17M derived: sum of 2 quarters · filed 2019-02-27 | -$17.47M 10-K · filed 2019-02-27 | ||||||||||||||||||
| 2017-09-30 | -$3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$13.28M 10-Q · filed 2018-11-14 | |||||||||||||||||||
| 2017-06-30 | -$9.30M 10-Q · filed 2018-08-09 | ||||||||||||||||||||
| 2014-03-31 | -$3.69M derived: 10-Q 147 month − 10-K 144 month · filed 2014-05-13 | -$5.56M derived: sum of 2 quarters · filed 2014-05-13 | -$7.24M derived: sum of 3 quarters · filed 2014-05-13 | -$8.21M derived: sum of 4 quarters · filed 2014-05-13 | -$106.40M 10-Q · filed 2014-05-13 | ||||||||||||||||
| 2013-12-31 | -$1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -$3.55M derived: sum of 2 quarters · filed 2014-03-20 | -$4.52M derived: sum of 3 quarters · filed 2014-03-20 | -$5.29M 10-K · filed 2014-03-20 | -$102.71M 10-K · filed 2014-03-20 | ||||||||||||||||
| 2013-09-30 | -$1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$2.65M derived: sum of 2 quarters · filed 2013-11-13 | -$3.42M 10-Q · filed 2013-11-13 | -$4.09M derived: sum of 4 quarters · filed 2014-03-20 | -$100.84M 10-Q · filed 2013-11-13 | ||||||||||||||||
| 2013-06-30 | -$976.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$1.74M 10-Q · filed 2013-08-13 | -$2.41M derived: sum of 3 quarters · filed 2014-03-20 | -$3.19M derived: sum of 4 quarters · filed 2014-03-20 | -$99.16M 10-Q · filed 2013-08-13 | ||||||||||||||||
| 2013-03-31 | -$764.00K 10-Q · filed 2013-05-13 | -$1.43M derived: sum of 2 quarters · filed 2014-03-20 | -$2.21M derived: sum of 3 quarters · filed 2014-03-20 | -$3.19M derived: sum of 4 quarters · filed 2014-03-20 | -$98.19M 10-Q · filed 2013-05-13 | ||||||||||||||||
| 2012-12-31 | -$670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -$1.45M derived: sum of 2 quarters · filed 2014-03-20 | -$2.42M derived: sum of 3 quarters · filed 2014-03-20 | -$4.08M 10-K · filed 2014-03-20 | -$97.42M 10-K · filed 2013-03-21 | ||||||||||||||||
| 2012-09-30 | -$775.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$1.75M derived: sum of 2 quarters · filed 2013-11-13 | -$3.41M 10-Q · filed 2013-11-13 | -$4.64M derived: sum of 4 quarters · filed 2013-11-13 | -$96.75M 10-Q · filed 2012-11-13 | ||||||||||||||||
| 2012-06-30 | -$977.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$2.63M 10-Q · filed 2013-08-13 | -$3.87M derived: sum of 3 quarters · filed 2013-08-13 | -$5.54M derived: sum of 4 quarters · filed 2013-08-13 | -$95.98M 10-Q · filed 2012-08-13 | ||||||||||||||||
| 2012-03-31 | -$1.66M 10-Q · filed 2013-05-13 | -$2.89M derived: sum of 2 quarters · filed 2013-05-13 | -$4.57M derived: sum of 3 quarters · filed 2013-05-13 | -$6.67M derived: sum of 4 quarters · filed 2013-05-13 | -$95.00M 10-Q · filed 2012-05-14 | ||||||||||||||||
| 2011-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | -$2.91M derived: sum of 2 quarters · filed 2013-03-21 | -$5.02M derived: sum of 3 quarters · filed 2013-03-21 | -$6.96M 10-K · filed 2013-03-21 | -$93.34M 10-K · filed 2012-03-27 | ||||||||||||||||
| 2011-09-30 | -$1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$3.78M derived: sum of 2 quarters · filed 2012-11-13 | -$5.72M 10-Q · filed 2012-11-13 | -$6.87M derived: sum of 4 quarters · filed 2012-11-13 | -$92.11M 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2011-06-30 | -$2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | -$4.05M 10-Q · filed 2012-08-13 | -$5.19M derived: sum of 3 quarters · filed 2012-08-13 | -$7.20M derived: sum of 4 quarters · filed 2012-08-13 | -$90.43M 10-Q · filed 2011-08-15 | ||||||||||||||||
| 2011-03-31 | -$1.94M 10-Q · filed 2012-05-14 | -$3.08M derived: sum of 2 quarters · filed 2012-05-14 | -$5.09M derived: sum of 3 quarters · filed 2012-05-14 | ||||||||||||||||||
| 2010-12-31 | -$1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | -$3.15M derived: sum of 2 quarters · filed 2012-03-27 | -$8.32M 10-K · filed 2012-03-27 | ||||||||||||||||||
| 2010-09-30 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$7.18M 10-Q · filed 2011-11-14 | |||||||||||||||||||
| 2010-06-30 | -$5.17M 10-Q · filed 2011-08-15 | ||||||||||||||||||||
| 2003-12-31 | -$95.98M 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |